Outcomes and side effects after first-line treatment with combination therapies for kidney cancer
This report looked at the results from 4 studies comparing [...]
This report looked at the results from 4 studies comparing [...]
This study looked at the safety and effectiveness of targeted [...]
A small phase 1b study of a new medicine called [...]
Results from a phase Ib/II study looking at lenvatinib plus [...]
In a small phase 2 study presented at the virtual [...]
Tivozanib is a drug that blocks the blood supply to [...]
Nivolumab alone and in combination with ipilimumab is used for the treatment of [...]
There are a number of immune checkpoint inhibitor drugs available [...]
Results from a phase II international trial led by researchers [...]
The combination of lenvatinib plus pembrolizumab has shown promise in [...]